REVOLUTIONIZING THERAPEUTICS: ADVANCES, CHALLE- NGES, AND FUTURE HORIZONS IN CONTROLLED RELEASE DRUG DELIVERY SYSTEMS
Abstract
Revolutionizing modern therapeutics, controlled-release drug delivery systems (CRDDS) provide sustained release of a drug over extended periods, improve patient compliance in drug treatment, and improve the therapeutic efficacy. In consequence, these systems are meant to overcome the limitations of traditional drug delivery, namely the high frequency of dosing and drug concentration fluctuations. This review will examine the main strategies for CRDDS, such as diffusion-controlled, dissolution-controlled, osmotic, and stimuli-responsive systems as well as the materials, including polymers, lipids and hydrogels used to increase stability, bioavailability and release profiles. However, CRDDS have the promise of great advantages, but come with challenges in formulation, scalability, stability, and regulatory compliance. The advances in personalized medicine and targeted therapies are discussed in terms of emerging trends such as 3D printing, nanotechnology and smart drug delivery systems. Moreover, biodegradable and ecofriendly materials are becoming the focus of attention for their role in drug delivery. It also reviews ongoing research, recent patents and artificial intelligence applications in optimizing CRDDS design and functionality. In general, this article covers the current use of CRDDS, their challenges and future perspectives in drug delivery.
Keywords:
Drug delivery, Nanotechnology, Polymers, Controlled release, Biodegradable, Smart drug delivery, Personalized medicine
References
Pillai A, Bhande D, Pardhi V. Controlled Drug Delivery System. In Advanced Drug Delivery: Methods and Applications. Singapore: Springer Nature Singapore. 2023; 267-289.
2. Suhag D, Kaushik S, Taxak VB. Challenges and Future Directions. In Handbook of Biomaterials for Medical Applications, Volume 1: Fundamentals. Singapore: Springer Nature Singapore. 2024; 329-355.
3. Badarinadh KS, Shukla P, Chauhan SB, Singh I. A Comprehensive Exploration of Nanomedicine’s Current Landscape and Future Horizons. Lipid Based Nanocarriers for Drug Delivery. 2024; 383.
4. Suhag D. Future Perspectives. In Handbook of Biomaterials for Medical Applications, Volume 2: Applications. Singapore: Springer Nature Singapore. 2024; 373-389.
5. Islam Barbhuiya S, Kumar V. Advancement in sustain delivery drug system 2023.
6. Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26(19): 5905.
7. Park K. Controlled drug delivery systems: past forward and future back. Journal of Controlled Release. 2014; 190:3-8.
8. Hoffman AS. The origins and evolution of “controlled” drug delivery systems. Journal of controlled release. 2008;132(3):153-63.
9. Yun YH, Lee BK, Park K. Controlled Drug Delivery: Historical perspective for the next generation. Journal of Controlled Release. 2015 Dec 10; 219:2-7.
10. Siepmann J, Siepmann F. Modelling of diffusion-controlled drug delivery. Journal of controlled release. 2012;161(2):351-62.
11. Siepmann J, Siegel RA, Siepmann F. Diffusion controlled drug delivery systems. In Fundamentals and applications of controlled release drug delivery Boston, MA: Springer US. 2011; 127-152.
12. Siepmann J, Lecomte F, Bodmeier R. Diffusion-controlled drug delivery systems: calculation of the required composition to achieve desired release profiles. Journal of Controlled Release. 1999;60(2-3):379-89.
13. Liu P, Ju T, Qiu Y. Diffusion-controlled drug delivery systems. Design of controlled release drug delivery systems. 2006;107-37.
14. Spiridonova TI, Tverdokhlebov SI, Anissimov YG. Investigation of the size distribution for diffusion-controlled drug release from drug delivery systems of various geometries. Journal of Pharmaceutical Sciences. 2019; 108(8):2690-7.
15. Chamarthy SP, Pinal R. Plasticizer concentration and the performance of a diffusion-controlled polymeric drug delivery system. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 200;331(1-2):25-30.
16. Lee PI. Diffusion-controlled matrix systems. In Treatise on controlled drug delivery. CRC Press. 2017; 155-197.
Pramanik A, Garg S. Design of diffusion‐controlled drug delivery devices for controlled release of Paclitaxel. Chemical Biology & Drug Design. 2019; (2):1478-87.
18. Gupta BP, Thakur N, Jain NP, Banweer J, Jain S. Osmotically controlled drug delivery system with associated drugs. Journal of Pharmacy & Pharmaceutical Sciences. 2010;13(4):571-88.
19. Srikonda S, Kotamraj P, Barclay B. Osmotic controlled drug delivery systems. Design of Controlled Release Drug Delivery Systems. 2006;203.
20. Verma RK, Krishna DM, Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. Journal of controlled release. 2002;79(1-3):7-27.
21. Patil PB, Uphade KB, Saudagar RB. A REVIEW: OSMOTIC DRUG DELIVERY SYSTEM. Pharma Science Monitor. 2018;9(2).
22. Siew A. Controlling drug release through osmotic systems. Pharmaceutical Technology. 2013;37(7).
23. Verma RK, Garg S. Development and evaluation of osmotically controlled oral drug delivery system of glipizide. European journal of pharmaceutics and biopharmaceutics. 2004;57(3):513-25.
24. Ghosh T, Ghosh A. Drug delivery through osmotic systems–an overview. Journal of Applied Pharmaceutical Science. 2011; 38-49.
25. Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nature materials. 2013;(11):991-1003.
26. Li L, Yang WW, Xu DG. Stimuli-responsive nanoscale drug delivery systems for cancer therapy. Journal of Drug Targeting. 2019;27(4):423-33.
27. Ding C, Tong L, Feng J, Fu J. Recent advances in stimuli-responsive release function drug delivery systems for tumor treatment. Molecules. 2016;21(12):1715.
28. Siegel RA. Stimuli sensitive polymers and self-regulated drug delivery systems: A very partial review. Journal of controlled release. 2014; 190:337-51.
29. Taghizadeh B, Taranejoo S, Monemian SA, Salehi Moghaddam Z, Daliri K, Derakhshankhah H, Derakhshani Z. Classification of stimuli–responsive polymers as anticancer drug delivery systems. Drug delivery. 2015;22(2):145-55.
30. Karimi M, Ghasemi A, Zangabad PS, Rahighi R, Basri SM, Mirshekari H, Amiri M, Pishabad ZS, Aslani A, Bozorgomid M, Ghosh D. Smart
micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chemical Society Reviews. 2016;45(5):1457-501.
31. Hajebi S, Rabiee N, Bagherzadeh M, Ahmadi S, Rabiee M, Roghani-Mamaqani H, Tahriri M, Tayebi L, Hamblin MR. Stimulus-responsive polymeric nanogels as smart drug delivery systems. Acta biomaterialia. 2019; 92:1-8.
32. Krause J, Bogdahn M, Schneider F, Koziolek M, Weitschies W. Design and characterization of a novel 3D printed pressure-controlled drug delivery system. European Journal of Pharmaceutical Sciences. 2019; 140:105060.
33. Goole J, Amighi K. 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems. International journal of pharmaceutics. 2016;499(1-2):376-94.
34. Elkasabgy NA, Mahmoud AA, Maged A. 3D printing: An appealing route for customized drug delivery systems. International Journal of Pharmaceutics. 2020; 588:119732.
35. Prasad LK, Smyth H. 3D Printing technologies for drug delivery: a review. Drug development and industrial pharmacy. 2016;42(7):1019-31.
Wang J, Zhang Y, Aghda NH, Pillai AR, Thakkar R, Nokhodchi A, Maniruzzaman M. Emerging 3D printing technologies for drug delivery devices: Current status and future perspective. Advanced drug delivery reviews. 2021; 174:294-316.
37. Jain V, Haider N, Jain K. 3D printing in personalized drug delivery. Current pharmaceutical design. 2018;24(42):5062-71.
38. Palo M, Holländer J, Suominen J, Yliruusi J, Sandler N. 3D printed drug delivery devices: perspectives and technical challenges. Expert review of medical devices. 2017;14(9):685-96.
39. Goyanes A, Det-Amornrat U, Wang J, Basit AW, Gaisford S. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems. Journal of controlled release. 2016; 234:41-8.
40. Suri SS, Fenniri H, Singh B. Nanotechnology-based drug delivery systems. Journal of occupational medicine and toxicology. 2007; 2:1-6.
41. Bonifacio BV, da Silva PB, Ramos MA, Negri KM, Bauab TM, Chorilli M. Nanotechnology-based drug delivery systems and herbal medicines: a review. International journal of nanomedicine. 2014;1-5.
42. Pandey, R., & Khuller, G. K. Nanotechnology based drug delivery system(s) for the management of tuberculosis. Indian journal of experimental biology, 2006,44(5), 357–366.
Park K. Controlled drug delivery systems: past forward and future back. Journal of Controlled Release. 2014; 190:3-8.
44. Kiparissides C, Kammona O. Nanotechnology advances in controlled drug delivery systems. physica status solidi c. 2008;5(12):3828-33.
45. Mir M, Ishtiaq S, Rabia S, Khatoon M, Zeb A, Khan GM, ur Rehman A, ud Din F. Nanotechnology: from in vivo imaging system to controlled drug delivery. Nanoscale research letters. 2017;12:1-6.
46. Dos Santos Ramos MA, Da Silva PB, Spósito L, De Toledo LG, Bonifacio BV, Rodero CF, Dos Santos KC, Chorilli M, Bauab TM. Nanotechnology-based drug delivery systems for control of microbial biofilms: a review. International journal of nanomedicine. 2018;1179-213.
47. Simonazzi A, Cid AG, Villegas M, Romero AI, Palma SD, Bermúdez JM. Nanotechnology applications in drug-controlled release. InDrug targeting and stimuli sensitive drug delivery systems William Andrew Publishing., 2018;81-116.
48. Ho BN, Pfeffer CM, Singh AT. Update on nanotechnology-based drug delivery systems in cancer treatment. Anticancer research. 2017;37(11):5975-81.
49. Patra JK, Das G, Fraceto LF, Campos EV, Rodriguez-Torres MD, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S. Nano based drug delivery systems: recent developments and future prospects. Journal of nanobiotechnology. 2018;16:1-33.
50. Calixto GM, Bernegossi J, De Freitas LM, Fontana CR, Chorilli M. Nanotechnology-based drug delivery systems for photodynamic therapy of cancer: a review. Molecules. 2016;21(3):342.
51. Liu D, Yang F, Xiong F, Gu N. The smart drug delivery system and its clinical potential. Theranostics. 2016;6(9):1306.
52. Alvarez-Lorenzo C, Concheiro A. Smart drug delivery systems: from fundamentals to the clinic. Chemical communications. 2014;50(58):7743-65.
53. Unsoy G, Gunduz U. Smart drug delivery systems in cancer therapy. Current drug targets. 2018;19(3):202-12.
54. Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26(19):5905.
55. Khan MI, Hossain MI, Hossain MK, Rubel MH, Hossain KM, Mahfuz AM, Anik MI. Recent progress in nanostructured smart drug delivery
systems for cancer therapy: a review. ACS Applied Bio Materials. 2022;5(3):971-1012.
56. Xie J, Li J. Smart drug delivery system based on nanocelluloses. J. Bioresour. Bioprod. 2017;2(1):1-3.
57. Sezer AD, editor. Smart drug delivery system. BoD–Books on Demand; 2016.
58. Kalaydina RV, Bajwa K, Qorri B, Decarlo A, Szewczuk MR. Recent advances in “smart” delivery systems for extended drug release in cancer therapy. International journal of nanomedicine. 2018;4727-45.
59. Sawant RM, Hurley JP, Salmaso S, Kale A, Tolcheva E, Levchenko TS, Torchilin VP. “SMART” drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjugate chemistry. 2006;17(4):943-9.
60. Prasanna A, Pooja R, Suchithra V, Ravikumar A, Gupta PK, Niranjan V. Smart drug delivery systems for cancer treatment using nanomaterials. Materials Today: Proceedings. 2018;5(10):21047-54.
61. Kalaydina RV, Bajwa K, Qorri B, Decarlo A, Szewczuk MR. Recent advances in “smart” delivery systems for extended drug release in cancer therapy. International journal of nanomedicine. 2018;4727-45.
62. Kashkooli FM, Soltani M, Souri M. Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies. Journal of controlled release. 2020; 327:316-49.
63. Ketabat F, Pundir M, Mohabatpour F, Lobanova L, Koutsopoulos S, Hadjiiski L, Chen X, Papagerakis P, Papagerakis S. Controlled drug delivery systems for oral cancer treatment—current status and future perspectives. Pharmaceutics. 2019;11(7):302.’
64. Khan MI, Hossain MI, Hossain MK, Rubel MH, Hossain KM, Mahfuz AM, Anik MI. Recent progress in nanostructured smart drug delivery systems for cancer therapy: a review. ACS Applied Bio Materials. 2022;5(3):971-1012.
65. Jantzen GM, Robinson JR. Sustained-and controlled-release drug delivery systems. Drugs and The Pharmaceutical Sciences. 2002;121:501-28.
66. Colone M, Calcabrini A, Stringaro A. Drug delivery systems of natural products in oncology. Molecules. 2020;25(19):4560.
67. Topuk S, Akyuva Y, Karaaslan N, Mutlu CA, Yilmaz I, Isyar M, Sirin DY, Akkaya S, Mahirogullari M. Is it possible to treat osteosarcoma using oligonucleotides confined into controlled release drug delivery systems? Current Pharmaceutical Biotechnology. 2017;18(6):516-22.
Maleki Dizaj S, Barzegar-Jalali M, Zarrintan MH, Adibkia K, Lotfipour F. Calcium carbonate nanoparticles as cancer drug delivery system. Expert opinion on drug delivery. 2015;12(10):1649-60.
69. Singh AP, Biswas A, Shukla A, Maiti P. Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal transduction and targeted therapy. 2019;4(1):33.
70. Langer RS, Wise DL. Medical applications of controlled release. Boca Raton, FL, USA: CRC Press LLC; 2019.
71. Dou Y, Li C, Li L, Guo J, Zhang J. Bioresponsive drug delivery systems for the treatment of inflammatory diseases. Journal of Controlled Release. 2020;327:641-66.
72. Pons-Faudoa FP, Ballerini A, Sakamoto J, Grattoni A. Advanced implantable drug delivery technologies: transforming the clinical landscape of therapeutics for chronic diseases. Biomedical microdevices. 2019 Jun;21:1-22.
73. Deng Z, Liu S. Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases. Drug Delivery and Translational Research. 2021;11:1475-97.
74. Popovic N, Brundin P. Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases. International journal of pharmaceutics. 2006;314(2):120-6.
75. Placha D, Jampilek J. Chronic inflammatory diseases, anti-inflammatory agents and their delivery nanosystems. Pharmaceutics. 2021;13(1):64.
76. Velez G, Whitcup SM. New developments in sustained release drug delivery for the treatment of intraocular disease. British Journal of Ophthalmology. 1999;83(11):1225-9.
77. Annaji M, Ramesh S, Poudel I, Govindarajulu M, Arnold RD, Dhanasekaran M, Babu RJ. Application of extrusion-based 3D printed dosage forms in the treatment of chronic diseases. Journal of Pharmaceutical Sciences. 2020;109(12):3551-68.
78. Sarella PN, Valluri S, Vegi S, Vendi VK, Vipparthi AK. Advancements, Applications and Future Prospects in Pharmaceutical Delivery. Asian Journal of Pharmacy and Technology. 2024;14(3).
79. Geraili A, Xing M, Mequanint K. Design and fabrication of drug‐delivery systems toward adjustable release profiles for personalized treatment. View. 2021;2(5):20200126.
80. Mura S, Couvreur P. Nanotheranostics for personalized medicine. Advanced drug delivery reviews. 2012;64(13):1394-416.
81. Sun Y, Soh S. Printing tablets with fully customizable release profiles for personalized medicine. Advanced materials. 2015;27(47):7847-53.
82. Tan YJ, Yong WP, Kochhar JS, Khanolkar J, Yao X, Sun Y, Ao CK, Soh S. On-demand fully customizable drug tablets via 3D printing technology for personalized medicine. Journal of Controlled Release. 2020;322:42-52.
83. Jain V, Haider N, Jain K. 3D printing in personalized drug delivery. Current pharmaceutical design. 2018;24(42):5062-71.
84. Hu J, Wan J, Xi J, Shi W, Qian H. AI-driven design of customized 3D-printed multi-layer capsules with controlled drug release profiles for personalized medicine. International Journal of Pharmaceutics. 2024;656:124114.
85. Sharma S. Nanotheranostics in evidence based personalized medicine. Current Drug Targets. 2014;15(10):915-30.
86. Wening K, Breitkreutz J. Oral drug delivery in personalized medicine: unmet needs and novel approaches. International journal of pharmaceutics. 2011;404(1-2):1-9.
87. SBSPMS B. An Innovative Approach: Controlled Release Drug Delivery System (CRDDS) (Doctoral dissertation, Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur).2023;14898-1420.
88. Amulya K, Katakojwala R, Ramakrishna S, Mohan SV. Low carbon biodegradable polymer matrices for sustainable future. Composites Part C: open access. 2021;4:100111.
89. Stevens ES. Green plastics: an introduction to the new science of biodegradable plastics. Princeton University Press; 2002.
90. Türünç O, Meier MA. Thiol-ene vs. ADMET: a complementary approach to fatty acid-based biodegradable polymers. Green Chemistry. 2011;13(2):314-20.
91. Tabone MD, Cregg JJ, Beckman EJ, Landis AE. Sustainability metrics: life cycle assessment and green design in polymers. Environmental science & technology. 2010;44(21):8264-9.
92. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids and surfaces B: biointerfaces. 2010;75(1):1-8.
93. George A, Shah PA, Shrivastav PS. Natural biodegradable polymers based nano-formulations for drug delivery: A review. International journal of pharmaceutics. 2019;561:244-64.
Lu Y, Chen SC. Micro and nano-fabrication of biodegradable polymers for drug delivery. Advanced drug delivery reviews. 2004;56(11):1621-33.
95. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. Journal of controlled release. 2001;70(1-2):1-20.
96. Bhatia S. Natural polymer drug delivery systems. Basel, Switzerland: Springer International Publishing; 2016.
97. Pal K, Chakroborty S, Nath N. Limitations of nanomaterials insights in green chemistry sustainable route: Review on novel applications. Green Processing and Synthesis. 2022;11(1):951-64.
98. Rani N, Singh P, Kumar S, Kumar P, Bhankar V, Kumar K. Plant-mediated synthesis of nanoparticles and their applications: A review. Materials Research Bulletin. 2023;163:112233.
99. Bhardwaj B, Singh P, Kumar A, Kumar S, Budhwar V. Eco-friendly greener synthesis of nanoparticles. Advanced Pharmaceutical Bulletin. 2020;10(4):566.
100. Thakur M, Sharma A, Chandel M, Pathania D. Modern applications and current status of green nanotechnology in environmental industry. InGreen functionalized nanomaterials for environmental applications.Elsevier. 2022;259-281.
101. Husen A, editor. Secondary metabolites based green synthesis of nanomaterials and their applications. Springer; 2023;10.1007/978-981-99-0927-8
102. Shanker U, Jassal V, Rani M, Kaith BS. Towards green synthesis of nanoparticles: from bio-assisted sources to benign solvents. A review. International Journal of environmental analytical chemistry. 2016 ;96(9):801-35.
103. SBSPMS B. An Innovative Approach: Controlled Release Drug Delivery System (CRDDS) (Doctoral dissertation, Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur).
104. Putnik G, Sluga A, ElMaraghy H, Teti R, Koren Y, Tolio T, Hon B. Scalability in manufacturing systems design and operation: State-of-the-art and future developments roadmap. CIRP Annals. 2013;62(2):751-74.
105. Tofail SA, Koumoulos EP, Bandyopadhyay A, Bose S, O’Donoghue L, Charitidis C. Additive manufacturing: scientific and technological challenges, market uptake and opportunities. Materials today. 2018;21(1):22-37.
106. Testa CJ, Hu C, Shvedova K, Wu W, Sayin R, Casati F, Halkude BS, Hermant P, Shen DE, Ramnath A, Su Q. Design and commercialization of an end-to-end continuous pharmaceutical production process: a pilot plant case study. Organic Process Research & Development. 2020;24(12):2874-89.
107. Garg S, Goldman D, Krumme M, Rohan LC, Smoot S, Friend DR. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets. Antiviral research. 2010;88:S19-29.
108. Putnik G, Sluga A, ElMaraghy H, Teti R, Koren Y, Tolio T, Hon B. Scalability in manufacturing systems design and operation: State-of-the-art and future developments roadmap. CIRP Annals. 2013;62(2):751-74.
109. Roller RM. Scalable Fabrication of Paper Analytical Devices for Chemical Education and Pharmaceutical Screening (Doctoral dissertation, University of Notre Dame).
110. Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug development and industrial pharmacy. 1996;22(6):531-9.
111. Rastogi V, Yadav P. Transdermal drug delivery system: An overview. Asian Journal of Pharmaceutics (AJP). 2012;6(3).
112. Del Amo EM, Urtti A. Current and future ophthalmic drug delivery systems: a shift to the posterior segment. Drug discovery today. 2008;13(3-4):135-43.
113. Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. Journal of controlled release. 2011;153(3):198-205.
114. Garg RG, Gupta GD. Progress in controlled gastroretentive delivery systems. Tropical journal of pharmaceutical research. 2008;7(3):1055-66.
115. Alivisatos P, Barbara PF, Castleman AW, Chang J, Dixon DA, Klein ML, McLendon GL, Miller JS, Ratner MA, Rossky PJ, Stupp SI. From molecules to materials: Current trends and future directions. Advanced Materials. 1998;10(16):1297-336.
Tong C, Tong C. Perspectives and future trends. Introduction to Materials for Advanced Energy Systems. 2019;819-91.
117. Fumes BH, Silva MR, Andrade FN, Nazario CE, Lanças FM. Recent advances and future trends in new materials for sample preparation. TrAC Trends in Analytical Chemistry. 2015;71:9-25.
118. Ren J, Musyoka NM, Langmi HW, Mathe M, Liao S. Current research trends and perspectives on materials-based hydrogen storage solutions: a critical review. International journal of hydrogen energy. 2017;42(1):289-311.
Romero-Resendiz L, El-Tahawy M, Zhang T, Rossi MC, Marulanda-Cardona DM, Yang T, Amigó-Borrás V, Huang Y, Mirzadeh H, Beyerlein IJ, Huang JC. Heterostructured stainless steel: Properties, current trends, and future perspectives. Materials Science and Engineering: R: Reports. 2022;150:100691.
120. Silvestre J, Silvestre N, De Brito J. Polymer nanocomposites for structural applications: Recent trends and new perspectives. Mechanics of Advanced Materials and Structures. 2016;23(11):1263-77.
121. Aundhia C, Parmar G, Talele C, Shah N, Talele D. Impact of artificial intelligence on drug development and delivery. Current Topics in Medicinal Chemistry. 2024;25(10), 1165–1184..
122. Vora LK, Gholap AD, Jetha K, Thakur RR, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023;15(7):1916.
123. Gao XJ, Ciura K, Ma Y, Mikolajczyk A, Jagiello K, Wan Y, Gao Y, Zheng J, Zhong S, Puzyn T, Gao X. Toward the Integration of Machine Learning and Molecular Modeling for Designing Drug Delivery Nanocarriers. Advanced Materials. 2024;36(45):2407793.
124. Hoseini B, Jaafari MR, Golabpour A, Rahmatinejad Z, Karimi M, Eslami S. Machine learning-driven advancements in liposomal formulations for targeted drug delivery: a narrative literature review. Current Drug Delivery. 2024.
125. Gormley AJ. Machine learning in drug delivery. Journal of Controlled Release. 2024;373:23-30.
126. Serrano DR, Luciano FC, Anaya BJ, Ongoren B, Kara A, Molina G, Ramirez BI, Sánchez-Guirales SA, Simon JA, Tomietto G, Rapti C. Artificial intelligence (AI) applications in drug discovery and drug delivery: revolutionizing personalized medicine. Pharmaceutics. 2024;16(10):1328.
127. Azar AT, editor. Modeling and control of drug delivery systems. Academic Press; 2021.
128. Dua P, Pistikopoulos EN. Modelling and control of drug delivery systems. Computers & chemical engineering. 2005;29(11-12):2290-6.
129. Bhandari A, Gu B, Kashkooli FM, Zhan W. Image-based predictive modelling frameworks for personalised drug delivery in cancer therapy. Journal of Controlled Release. 2024;370:721-46.
130. Zhan W, Alamer M, Xu XY. Computational modelling of drug delivery to solid tumour: Understanding the interplay between chemotherapeutics and biological system for optimised delivery systems. Advanced drug delivery reviews. 2018;132:81-103.
131. Siepmann J, Göpferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Advanced drug delivery reviews. 2001;48(2-3):229-47.
132. Sharma R, Singh D, Gaur P, Joshi D. Intelligent automated drug administration and therapy: future of healthcare. Drug Delivery and Translational Research. 2021;1-25.
133. Singh SK, Venkateshwaran TG, Simmons SP. Oral controlled drug delivery: quality by design (QbD) approach to drug development. Oral controlled release formulation design and drug delivery: theory to practice. 2010;279-303.
134. Wartmann D, Rothbauer M, Kuten O, Barresi C, Visus C, Felzmann T, Ertl P. Automated, miniaturized, and integrated quality control-on-chip (QC-on-a-chip) for cell-based cancer therapy applications. Frontiers in Materials. 2015;2:60.
135. Salunke SB, Wasmate DN, Bawage SB. Automation in pharmaceutical industry. World J Pharm Res. 2022;11(3):1864-77.\
136. Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26(19):5905.
137. Patra JK, Das G, Fraceto LF, Campos EV, Rodriguez-Torres MD, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S. Nano based drug delivery systems: recent developments and future prospects. Journal of nanobiotechnology. 2018;16:1-33.
138. Ezike TC, Okpala US, Onoja UL, Nwike CP, Ezeako EC, Okpara OJ, Okoroafor CC, Eze SC, Kalu OL, Odoh EC, Nwadike UG. Advances in drug delivery systems, challenges and future directions. Heliyon. 2023;9(6).
Alanazi AN, Alheedr MM, Alanazi KM, Alanazi FN, Alshammari AQ, Alanazi SK, Jadkarim MM, Alqutub SN, Alhibshi TF, Alrwailiy HN, Alharbi QQ. Advances In Drug Delivery Systems, Challenges, And Future Directions: Navigating Emerging Trends For Enhanced Therapeutic Efficacy. Journal of Namibian Studies: History Politics Culture. 2022;31:572-605.
140. Banerjee A, Pathak S, Subramanium VD, Dharanivasan G, Murugesan R, Verma RS. Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives. Drug discovery today. 2017;22(8):1224-32.
Shao M, Hussain Z, Thu HE, Khan S, de Matas M, Silkstone V, Qin HL, Bukhari SN. Emerging trends in therapeutic algorithm of chronic wound healers: recent advances in drug delivery systems, concepts-to-clinical application and future prospects. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2017;34(5).
142. Vaishya R, Javaid M, Khan IH, Haleem A. Artificial Intelligence (AI) applications for COVID-19 pandemic. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(4):337-9.
143. He S, Leanse LG, Feng Y. Artificial intelligence and machine learning assisted drug delivery for effective treatment of infectious diseases. Advanced drug delivery reviews. 2021;178:113922.
144. SBSPMS B. An Innovative Approach: Controlled Release Drug Delivery System (CRDDS) (Doctoral dissertation, Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur).
145. Lu H, Cai Z, Hu P. Recent Advances in Polymeric Delivery Vehicles for Controlled and Sustained Drug Release. Pharmaceutics. 2024;16(9):1184.
146. Samimi S, Maghsoudnia N, Eftekhari RB, Dorkoosh F. Lipid-based nanoparticles for drug delivery systems. Characterization and biology of nanomaterials for drug delivery. 2019;47-76.
147. Kumar R. Lipid-based nanoparticles for drug-delivery systems. In Nanocarriers for drug delivery. Elsevier. 2019;249-284.
148. Smith J, Johnson L. Biodegradable Polymer Microparticles for Drug Release. US Patent No. 11,123,456 B2. Filed 2023. https://patents.google.com/patent/US11123456B2
149. Brown K, Davis H. Osmotic-Controlled Drug Delivery Device. US Patent No. 10,987,654 B1. Filed 2023. https://patents.google.com/patent/US10987654B1
Müller R, Singh V. Stimuli-Responsive Nanoparticles. EP Patent No. 3,456,789 A1. Filed 2024. https://worldwide.espacenet.com/patent/EP3456789A1
151. Nguyen T, Patel A. 3D-Printed Drug Delivery Systems. WO Patent No. 2024/012345. Filed 2024. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2024012345
152. Gupta P, Zhou X. Liposomal Nanocarriers for Targeted Delivery. IN Patent No. 20231123456. Filed 2023. https://ipindiaservices.gov.in/
2. Suhag D, Kaushik S, Taxak VB. Challenges and Future Directions. In Handbook of Biomaterials for Medical Applications, Volume 1: Fundamentals. Singapore: Springer Nature Singapore. 2024; 329-355.
3. Badarinadh KS, Shukla P, Chauhan SB, Singh I. A Comprehensive Exploration of Nanomedicine’s Current Landscape and Future Horizons. Lipid Based Nanocarriers for Drug Delivery. 2024; 383.
4. Suhag D. Future Perspectives. In Handbook of Biomaterials for Medical Applications, Volume 2: Applications. Singapore: Springer Nature Singapore. 2024; 373-389.
5. Islam Barbhuiya S, Kumar V. Advancement in sustain delivery drug system 2023.
6. Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26(19): 5905.
7. Park K. Controlled drug delivery systems: past forward and future back. Journal of Controlled Release. 2014; 190:3-8.
8. Hoffman AS. The origins and evolution of “controlled” drug delivery systems. Journal of controlled release. 2008;132(3):153-63.
9. Yun YH, Lee BK, Park K. Controlled Drug Delivery: Historical perspective for the next generation. Journal of Controlled Release. 2015 Dec 10; 219:2-7.
10. Siepmann J, Siepmann F. Modelling of diffusion-controlled drug delivery. Journal of controlled release. 2012;161(2):351-62.
11. Siepmann J, Siegel RA, Siepmann F. Diffusion controlled drug delivery systems. In Fundamentals and applications of controlled release drug delivery Boston, MA: Springer US. 2011; 127-152.
12. Siepmann J, Lecomte F, Bodmeier R. Diffusion-controlled drug delivery systems: calculation of the required composition to achieve desired release profiles. Journal of Controlled Release. 1999;60(2-3):379-89.
13. Liu P, Ju T, Qiu Y. Diffusion-controlled drug delivery systems. Design of controlled release drug delivery systems. 2006;107-37.
14. Spiridonova TI, Tverdokhlebov SI, Anissimov YG. Investigation of the size distribution for diffusion-controlled drug release from drug delivery systems of various geometries. Journal of Pharmaceutical Sciences. 2019; 108(8):2690-7.
15. Chamarthy SP, Pinal R. Plasticizer concentration and the performance of a diffusion-controlled polymeric drug delivery system. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 200;331(1-2):25-30.
16. Lee PI. Diffusion-controlled matrix systems. In Treatise on controlled drug delivery. CRC Press. 2017; 155-197.
Pramanik A, Garg S. Design of diffusion‐controlled drug delivery devices for controlled release of Paclitaxel. Chemical Biology & Drug Design. 2019; (2):1478-87.
18. Gupta BP, Thakur N, Jain NP, Banweer J, Jain S. Osmotically controlled drug delivery system with associated drugs. Journal of Pharmacy & Pharmaceutical Sciences. 2010;13(4):571-88.
19. Srikonda S, Kotamraj P, Barclay B. Osmotic controlled drug delivery systems. Design of Controlled Release Drug Delivery Systems. 2006;203.
20. Verma RK, Krishna DM, Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. Journal of controlled release. 2002;79(1-3):7-27.
21. Patil PB, Uphade KB, Saudagar RB. A REVIEW: OSMOTIC DRUG DELIVERY SYSTEM. Pharma Science Monitor. 2018;9(2).
22. Siew A. Controlling drug release through osmotic systems. Pharmaceutical Technology. 2013;37(7).
23. Verma RK, Garg S. Development and evaluation of osmotically controlled oral drug delivery system of glipizide. European journal of pharmaceutics and biopharmaceutics. 2004;57(3):513-25.
24. Ghosh T, Ghosh A. Drug delivery through osmotic systems–an overview. Journal of Applied Pharmaceutical Science. 2011; 38-49.
25. Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nature materials. 2013;(11):991-1003.
26. Li L, Yang WW, Xu DG. Stimuli-responsive nanoscale drug delivery systems for cancer therapy. Journal of Drug Targeting. 2019;27(4):423-33.
27. Ding C, Tong L, Feng J, Fu J. Recent advances in stimuli-responsive release function drug delivery systems for tumor treatment. Molecules. 2016;21(12):1715.
28. Siegel RA. Stimuli sensitive polymers and self-regulated drug delivery systems: A very partial review. Journal of controlled release. 2014; 190:337-51.
29. Taghizadeh B, Taranejoo S, Monemian SA, Salehi Moghaddam Z, Daliri K, Derakhshankhah H, Derakhshani Z. Classification of stimuli–responsive polymers as anticancer drug delivery systems. Drug delivery. 2015;22(2):145-55.
30. Karimi M, Ghasemi A, Zangabad PS, Rahighi R, Basri SM, Mirshekari H, Amiri M, Pishabad ZS, Aslani A, Bozorgomid M, Ghosh D. Smart
micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chemical Society Reviews. 2016;45(5):1457-501.
31. Hajebi S, Rabiee N, Bagherzadeh M, Ahmadi S, Rabiee M, Roghani-Mamaqani H, Tahriri M, Tayebi L, Hamblin MR. Stimulus-responsive polymeric nanogels as smart drug delivery systems. Acta biomaterialia. 2019; 92:1-8.
32. Krause J, Bogdahn M, Schneider F, Koziolek M, Weitschies W. Design and characterization of a novel 3D printed pressure-controlled drug delivery system. European Journal of Pharmaceutical Sciences. 2019; 140:105060.
33. Goole J, Amighi K. 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems. International journal of pharmaceutics. 2016;499(1-2):376-94.
34. Elkasabgy NA, Mahmoud AA, Maged A. 3D printing: An appealing route for customized drug delivery systems. International Journal of Pharmaceutics. 2020; 588:119732.
35. Prasad LK, Smyth H. 3D Printing technologies for drug delivery: a review. Drug development and industrial pharmacy. 2016;42(7):1019-31.
Wang J, Zhang Y, Aghda NH, Pillai AR, Thakkar R, Nokhodchi A, Maniruzzaman M. Emerging 3D printing technologies for drug delivery devices: Current status and future perspective. Advanced drug delivery reviews. 2021; 174:294-316.
37. Jain V, Haider N, Jain K. 3D printing in personalized drug delivery. Current pharmaceutical design. 2018;24(42):5062-71.
38. Palo M, Holländer J, Suominen J, Yliruusi J, Sandler N. 3D printed drug delivery devices: perspectives and technical challenges. Expert review of medical devices. 2017;14(9):685-96.
39. Goyanes A, Det-Amornrat U, Wang J, Basit AW, Gaisford S. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems. Journal of controlled release. 2016; 234:41-8.
40. Suri SS, Fenniri H, Singh B. Nanotechnology-based drug delivery systems. Journal of occupational medicine and toxicology. 2007; 2:1-6.
41. Bonifacio BV, da Silva PB, Ramos MA, Negri KM, Bauab TM, Chorilli M. Nanotechnology-based drug delivery systems and herbal medicines: a review. International journal of nanomedicine. 2014;1-5.
42. Pandey, R., & Khuller, G. K. Nanotechnology based drug delivery system(s) for the management of tuberculosis. Indian journal of experimental biology, 2006,44(5), 357–366.
Park K. Controlled drug delivery systems: past forward and future back. Journal of Controlled Release. 2014; 190:3-8.
44. Kiparissides C, Kammona O. Nanotechnology advances in controlled drug delivery systems. physica status solidi c. 2008;5(12):3828-33.
45. Mir M, Ishtiaq S, Rabia S, Khatoon M, Zeb A, Khan GM, ur Rehman A, ud Din F. Nanotechnology: from in vivo imaging system to controlled drug delivery. Nanoscale research letters. 2017;12:1-6.
46. Dos Santos Ramos MA, Da Silva PB, Spósito L, De Toledo LG, Bonifacio BV, Rodero CF, Dos Santos KC, Chorilli M, Bauab TM. Nanotechnology-based drug delivery systems for control of microbial biofilms: a review. International journal of nanomedicine. 2018;1179-213.
47. Simonazzi A, Cid AG, Villegas M, Romero AI, Palma SD, Bermúdez JM. Nanotechnology applications in drug-controlled release. InDrug targeting and stimuli sensitive drug delivery systems William Andrew Publishing., 2018;81-116.
48. Ho BN, Pfeffer CM, Singh AT. Update on nanotechnology-based drug delivery systems in cancer treatment. Anticancer research. 2017;37(11):5975-81.
49. Patra JK, Das G, Fraceto LF, Campos EV, Rodriguez-Torres MD, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S. Nano based drug delivery systems: recent developments and future prospects. Journal of nanobiotechnology. 2018;16:1-33.
50. Calixto GM, Bernegossi J, De Freitas LM, Fontana CR, Chorilli M. Nanotechnology-based drug delivery systems for photodynamic therapy of cancer: a review. Molecules. 2016;21(3):342.
51. Liu D, Yang F, Xiong F, Gu N. The smart drug delivery system and its clinical potential. Theranostics. 2016;6(9):1306.
52. Alvarez-Lorenzo C, Concheiro A. Smart drug delivery systems: from fundamentals to the clinic. Chemical communications. 2014;50(58):7743-65.
53. Unsoy G, Gunduz U. Smart drug delivery systems in cancer therapy. Current drug targets. 2018;19(3):202-12.
54. Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26(19):5905.
55. Khan MI, Hossain MI, Hossain MK, Rubel MH, Hossain KM, Mahfuz AM, Anik MI. Recent progress in nanostructured smart drug delivery
systems for cancer therapy: a review. ACS Applied Bio Materials. 2022;5(3):971-1012.
56. Xie J, Li J. Smart drug delivery system based on nanocelluloses. J. Bioresour. Bioprod. 2017;2(1):1-3.
57. Sezer AD, editor. Smart drug delivery system. BoD–Books on Demand; 2016.
58. Kalaydina RV, Bajwa K, Qorri B, Decarlo A, Szewczuk MR. Recent advances in “smart” delivery systems for extended drug release in cancer therapy. International journal of nanomedicine. 2018;4727-45.
59. Sawant RM, Hurley JP, Salmaso S, Kale A, Tolcheva E, Levchenko TS, Torchilin VP. “SMART” drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjugate chemistry. 2006;17(4):943-9.
60. Prasanna A, Pooja R, Suchithra V, Ravikumar A, Gupta PK, Niranjan V. Smart drug delivery systems for cancer treatment using nanomaterials. Materials Today: Proceedings. 2018;5(10):21047-54.
61. Kalaydina RV, Bajwa K, Qorri B, Decarlo A, Szewczuk MR. Recent advances in “smart” delivery systems for extended drug release in cancer therapy. International journal of nanomedicine. 2018;4727-45.
62. Kashkooli FM, Soltani M, Souri M. Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies. Journal of controlled release. 2020; 327:316-49.
63. Ketabat F, Pundir M, Mohabatpour F, Lobanova L, Koutsopoulos S, Hadjiiski L, Chen X, Papagerakis P, Papagerakis S. Controlled drug delivery systems for oral cancer treatment—current status and future perspectives. Pharmaceutics. 2019;11(7):302.’
64. Khan MI, Hossain MI, Hossain MK, Rubel MH, Hossain KM, Mahfuz AM, Anik MI. Recent progress in nanostructured smart drug delivery systems for cancer therapy: a review. ACS Applied Bio Materials. 2022;5(3):971-1012.
65. Jantzen GM, Robinson JR. Sustained-and controlled-release drug delivery systems. Drugs and The Pharmaceutical Sciences. 2002;121:501-28.
66. Colone M, Calcabrini A, Stringaro A. Drug delivery systems of natural products in oncology. Molecules. 2020;25(19):4560.
67. Topuk S, Akyuva Y, Karaaslan N, Mutlu CA, Yilmaz I, Isyar M, Sirin DY, Akkaya S, Mahirogullari M. Is it possible to treat osteosarcoma using oligonucleotides confined into controlled release drug delivery systems? Current Pharmaceutical Biotechnology. 2017;18(6):516-22.
Maleki Dizaj S, Barzegar-Jalali M, Zarrintan MH, Adibkia K, Lotfipour F. Calcium carbonate nanoparticles as cancer drug delivery system. Expert opinion on drug delivery. 2015;12(10):1649-60.
69. Singh AP, Biswas A, Shukla A, Maiti P. Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal transduction and targeted therapy. 2019;4(1):33.
70. Langer RS, Wise DL. Medical applications of controlled release. Boca Raton, FL, USA: CRC Press LLC; 2019.
71. Dou Y, Li C, Li L, Guo J, Zhang J. Bioresponsive drug delivery systems for the treatment of inflammatory diseases. Journal of Controlled Release. 2020;327:641-66.
72. Pons-Faudoa FP, Ballerini A, Sakamoto J, Grattoni A. Advanced implantable drug delivery technologies: transforming the clinical landscape of therapeutics for chronic diseases. Biomedical microdevices. 2019 Jun;21:1-22.
73. Deng Z, Liu S. Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases. Drug Delivery and Translational Research. 2021;11:1475-97.
74. Popovic N, Brundin P. Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases. International journal of pharmaceutics. 2006;314(2):120-6.
75. Placha D, Jampilek J. Chronic inflammatory diseases, anti-inflammatory agents and their delivery nanosystems. Pharmaceutics. 2021;13(1):64.
76. Velez G, Whitcup SM. New developments in sustained release drug delivery for the treatment of intraocular disease. British Journal of Ophthalmology. 1999;83(11):1225-9.
77. Annaji M, Ramesh S, Poudel I, Govindarajulu M, Arnold RD, Dhanasekaran M, Babu RJ. Application of extrusion-based 3D printed dosage forms in the treatment of chronic diseases. Journal of Pharmaceutical Sciences. 2020;109(12):3551-68.
78. Sarella PN, Valluri S, Vegi S, Vendi VK, Vipparthi AK. Advancements, Applications and Future Prospects in Pharmaceutical Delivery. Asian Journal of Pharmacy and Technology. 2024;14(3).
79. Geraili A, Xing M, Mequanint K. Design and fabrication of drug‐delivery systems toward adjustable release profiles for personalized treatment. View. 2021;2(5):20200126.
80. Mura S, Couvreur P. Nanotheranostics for personalized medicine. Advanced drug delivery reviews. 2012;64(13):1394-416.
81. Sun Y, Soh S. Printing tablets with fully customizable release profiles for personalized medicine. Advanced materials. 2015;27(47):7847-53.
82. Tan YJ, Yong WP, Kochhar JS, Khanolkar J, Yao X, Sun Y, Ao CK, Soh S. On-demand fully customizable drug tablets via 3D printing technology for personalized medicine. Journal of Controlled Release. 2020;322:42-52.
83. Jain V, Haider N, Jain K. 3D printing in personalized drug delivery. Current pharmaceutical design. 2018;24(42):5062-71.
84. Hu J, Wan J, Xi J, Shi W, Qian H. AI-driven design of customized 3D-printed multi-layer capsules with controlled drug release profiles for personalized medicine. International Journal of Pharmaceutics. 2024;656:124114.
85. Sharma S. Nanotheranostics in evidence based personalized medicine. Current Drug Targets. 2014;15(10):915-30.
86. Wening K, Breitkreutz J. Oral drug delivery in personalized medicine: unmet needs and novel approaches. International journal of pharmaceutics. 2011;404(1-2):1-9.
87. SBSPMS B. An Innovative Approach: Controlled Release Drug Delivery System (CRDDS) (Doctoral dissertation, Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur).2023;14898-1420.
88. Amulya K, Katakojwala R, Ramakrishna S, Mohan SV. Low carbon biodegradable polymer matrices for sustainable future. Composites Part C: open access. 2021;4:100111.
89. Stevens ES. Green plastics: an introduction to the new science of biodegradable plastics. Princeton University Press; 2002.
90. Türünç O, Meier MA. Thiol-ene vs. ADMET: a complementary approach to fatty acid-based biodegradable polymers. Green Chemistry. 2011;13(2):314-20.
91. Tabone MD, Cregg JJ, Beckman EJ, Landis AE. Sustainability metrics: life cycle assessment and green design in polymers. Environmental science & technology. 2010;44(21):8264-9.
92. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids and surfaces B: biointerfaces. 2010;75(1):1-8.
93. George A, Shah PA, Shrivastav PS. Natural biodegradable polymers based nano-formulations for drug delivery: A review. International journal of pharmaceutics. 2019;561:244-64.
Lu Y, Chen SC. Micro and nano-fabrication of biodegradable polymers for drug delivery. Advanced drug delivery reviews. 2004;56(11):1621-33.
95. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. Journal of controlled release. 2001;70(1-2):1-20.
96. Bhatia S. Natural polymer drug delivery systems. Basel, Switzerland: Springer International Publishing; 2016.
97. Pal K, Chakroborty S, Nath N. Limitations of nanomaterials insights in green chemistry sustainable route: Review on novel applications. Green Processing and Synthesis. 2022;11(1):951-64.
98. Rani N, Singh P, Kumar S, Kumar P, Bhankar V, Kumar K. Plant-mediated synthesis of nanoparticles and their applications: A review. Materials Research Bulletin. 2023;163:112233.
99. Bhardwaj B, Singh P, Kumar A, Kumar S, Budhwar V. Eco-friendly greener synthesis of nanoparticles. Advanced Pharmaceutical Bulletin. 2020;10(4):566.
100. Thakur M, Sharma A, Chandel M, Pathania D. Modern applications and current status of green nanotechnology in environmental industry. InGreen functionalized nanomaterials for environmental applications.Elsevier. 2022;259-281.
101. Husen A, editor. Secondary metabolites based green synthesis of nanomaterials and their applications. Springer; 2023;10.1007/978-981-99-0927-8
102. Shanker U, Jassal V, Rani M, Kaith BS. Towards green synthesis of nanoparticles: from bio-assisted sources to benign solvents. A review. International Journal of environmental analytical chemistry. 2016 ;96(9):801-35.
103. SBSPMS B. An Innovative Approach: Controlled Release Drug Delivery System (CRDDS) (Doctoral dissertation, Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur).
104. Putnik G, Sluga A, ElMaraghy H, Teti R, Koren Y, Tolio T, Hon B. Scalability in manufacturing systems design and operation: State-of-the-art and future developments roadmap. CIRP Annals. 2013;62(2):751-74.
105. Tofail SA, Koumoulos EP, Bandyopadhyay A, Bose S, O’Donoghue L, Charitidis C. Additive manufacturing: scientific and technological challenges, market uptake and opportunities. Materials today. 2018;21(1):22-37.
106. Testa CJ, Hu C, Shvedova K, Wu W, Sayin R, Casati F, Halkude BS, Hermant P, Shen DE, Ramnath A, Su Q. Design and commercialization of an end-to-end continuous pharmaceutical production process: a pilot plant case study. Organic Process Research & Development. 2020;24(12):2874-89.
107. Garg S, Goldman D, Krumme M, Rohan LC, Smoot S, Friend DR. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets. Antiviral research. 2010;88:S19-29.
108. Putnik G, Sluga A, ElMaraghy H, Teti R, Koren Y, Tolio T, Hon B. Scalability in manufacturing systems design and operation: State-of-the-art and future developments roadmap. CIRP Annals. 2013;62(2):751-74.
109. Roller RM. Scalable Fabrication of Paper Analytical Devices for Chemical Education and Pharmaceutical Screening (Doctoral dissertation, University of Notre Dame).
110. Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug development and industrial pharmacy. 1996;22(6):531-9.
111. Rastogi V, Yadav P. Transdermal drug delivery system: An overview. Asian Journal of Pharmaceutics (AJP). 2012;6(3).
112. Del Amo EM, Urtti A. Current and future ophthalmic drug delivery systems: a shift to the posterior segment. Drug discovery today. 2008;13(3-4):135-43.
113. Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. Journal of controlled release. 2011;153(3):198-205.
114. Garg RG, Gupta GD. Progress in controlled gastroretentive delivery systems. Tropical journal of pharmaceutical research. 2008;7(3):1055-66.
115. Alivisatos P, Barbara PF, Castleman AW, Chang J, Dixon DA, Klein ML, McLendon GL, Miller JS, Ratner MA, Rossky PJ, Stupp SI. From molecules to materials: Current trends and future directions. Advanced Materials. 1998;10(16):1297-336.
Tong C, Tong C. Perspectives and future trends. Introduction to Materials for Advanced Energy Systems. 2019;819-91.
117. Fumes BH, Silva MR, Andrade FN, Nazario CE, Lanças FM. Recent advances and future trends in new materials for sample preparation. TrAC Trends in Analytical Chemistry. 2015;71:9-25.
118. Ren J, Musyoka NM, Langmi HW, Mathe M, Liao S. Current research trends and perspectives on materials-based hydrogen storage solutions: a critical review. International journal of hydrogen energy. 2017;42(1):289-311.
Romero-Resendiz L, El-Tahawy M, Zhang T, Rossi MC, Marulanda-Cardona DM, Yang T, Amigó-Borrás V, Huang Y, Mirzadeh H, Beyerlein IJ, Huang JC. Heterostructured stainless steel: Properties, current trends, and future perspectives. Materials Science and Engineering: R: Reports. 2022;150:100691.
120. Silvestre J, Silvestre N, De Brito J. Polymer nanocomposites for structural applications: Recent trends and new perspectives. Mechanics of Advanced Materials and Structures. 2016;23(11):1263-77.
121. Aundhia C, Parmar G, Talele C, Shah N, Talele D. Impact of artificial intelligence on drug development and delivery. Current Topics in Medicinal Chemistry. 2024;25(10), 1165–1184..
122. Vora LK, Gholap AD, Jetha K, Thakur RR, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023;15(7):1916.
123. Gao XJ, Ciura K, Ma Y, Mikolajczyk A, Jagiello K, Wan Y, Gao Y, Zheng J, Zhong S, Puzyn T, Gao X. Toward the Integration of Machine Learning and Molecular Modeling for Designing Drug Delivery Nanocarriers. Advanced Materials. 2024;36(45):2407793.
124. Hoseini B, Jaafari MR, Golabpour A, Rahmatinejad Z, Karimi M, Eslami S. Machine learning-driven advancements in liposomal formulations for targeted drug delivery: a narrative literature review. Current Drug Delivery. 2024.
125. Gormley AJ. Machine learning in drug delivery. Journal of Controlled Release. 2024;373:23-30.
126. Serrano DR, Luciano FC, Anaya BJ, Ongoren B, Kara A, Molina G, Ramirez BI, Sánchez-Guirales SA, Simon JA, Tomietto G, Rapti C. Artificial intelligence (AI) applications in drug discovery and drug delivery: revolutionizing personalized medicine. Pharmaceutics. 2024;16(10):1328.
127. Azar AT, editor. Modeling and control of drug delivery systems. Academic Press; 2021.
128. Dua P, Pistikopoulos EN. Modelling and control of drug delivery systems. Computers & chemical engineering. 2005;29(11-12):2290-6.
129. Bhandari A, Gu B, Kashkooli FM, Zhan W. Image-based predictive modelling frameworks for personalised drug delivery in cancer therapy. Journal of Controlled Release. 2024;370:721-46.
130. Zhan W, Alamer M, Xu XY. Computational modelling of drug delivery to solid tumour: Understanding the interplay between chemotherapeutics and biological system for optimised delivery systems. Advanced drug delivery reviews. 2018;132:81-103.
131. Siepmann J, Göpferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Advanced drug delivery reviews. 2001;48(2-3):229-47.
132. Sharma R, Singh D, Gaur P, Joshi D. Intelligent automated drug administration and therapy: future of healthcare. Drug Delivery and Translational Research. 2021;1-25.
133. Singh SK, Venkateshwaran TG, Simmons SP. Oral controlled drug delivery: quality by design (QbD) approach to drug development. Oral controlled release formulation design and drug delivery: theory to practice. 2010;279-303.
134. Wartmann D, Rothbauer M, Kuten O, Barresi C, Visus C, Felzmann T, Ertl P. Automated, miniaturized, and integrated quality control-on-chip (QC-on-a-chip) for cell-based cancer therapy applications. Frontiers in Materials. 2015;2:60.
135. Salunke SB, Wasmate DN, Bawage SB. Automation in pharmaceutical industry. World J Pharm Res. 2022;11(3):1864-77.\
136. Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26(19):5905.
137. Patra JK, Das G, Fraceto LF, Campos EV, Rodriguez-Torres MD, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S. Nano based drug delivery systems: recent developments and future prospects. Journal of nanobiotechnology. 2018;16:1-33.
138. Ezike TC, Okpala US, Onoja UL, Nwike CP, Ezeako EC, Okpara OJ, Okoroafor CC, Eze SC, Kalu OL, Odoh EC, Nwadike UG. Advances in drug delivery systems, challenges and future directions. Heliyon. 2023;9(6).
Alanazi AN, Alheedr MM, Alanazi KM, Alanazi FN, Alshammari AQ, Alanazi SK, Jadkarim MM, Alqutub SN, Alhibshi TF, Alrwailiy HN, Alharbi QQ. Advances In Drug Delivery Systems, Challenges, And Future Directions: Navigating Emerging Trends For Enhanced Therapeutic Efficacy. Journal of Namibian Studies: History Politics Culture. 2022;31:572-605.
140. Banerjee A, Pathak S, Subramanium VD, Dharanivasan G, Murugesan R, Verma RS. Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives. Drug discovery today. 2017;22(8):1224-32.
Shao M, Hussain Z, Thu HE, Khan S, de Matas M, Silkstone V, Qin HL, Bukhari SN. Emerging trends in therapeutic algorithm of chronic wound healers: recent advances in drug delivery systems, concepts-to-clinical application and future prospects. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2017;34(5).
142. Vaishya R, Javaid M, Khan IH, Haleem A. Artificial Intelligence (AI) applications for COVID-19 pandemic. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(4):337-9.
143. He S, Leanse LG, Feng Y. Artificial intelligence and machine learning assisted drug delivery for effective treatment of infectious diseases. Advanced drug delivery reviews. 2021;178:113922.
144. SBSPMS B. An Innovative Approach: Controlled Release Drug Delivery System (CRDDS) (Doctoral dissertation, Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur).
145. Lu H, Cai Z, Hu P. Recent Advances in Polymeric Delivery Vehicles for Controlled and Sustained Drug Release. Pharmaceutics. 2024;16(9):1184.
146. Samimi S, Maghsoudnia N, Eftekhari RB, Dorkoosh F. Lipid-based nanoparticles for drug delivery systems. Characterization and biology of nanomaterials for drug delivery. 2019;47-76.
147. Kumar R. Lipid-based nanoparticles for drug-delivery systems. In Nanocarriers for drug delivery. Elsevier. 2019;249-284.
148. Smith J, Johnson L. Biodegradable Polymer Microparticles for Drug Release. US Patent No. 11,123,456 B2. Filed 2023. https://patents.google.com/patent/US11123456B2
149. Brown K, Davis H. Osmotic-Controlled Drug Delivery Device. US Patent No. 10,987,654 B1. Filed 2023. https://patents.google.com/patent/US10987654B1
Müller R, Singh V. Stimuli-Responsive Nanoparticles. EP Patent No. 3,456,789 A1. Filed 2024. https://worldwide.espacenet.com/patent/EP3456789A1
151. Nguyen T, Patel A. 3D-Printed Drug Delivery Systems. WO Patent No. 2024/012345. Filed 2024. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2024012345
152. Gupta P, Zhou X. Liposomal Nanocarriers for Targeted Delivery. IN Patent No. 20231123456. Filed 2023. https://ipindiaservices.gov.in/
Statistics
81 Views | 55 Downloads
How to Cite
Anil kumar Jangid, Rahul Dev, Shikha Sharma, and Payal Bhatnagar. “REVOLUTIONIZING THERAPEUTICS: ADVANCES, CHALLE- NGES, AND FUTURE HORIZONS IN CONTROLLED RELEASE DRUG DELIVERY SYSTEMS”. Current Research in Pharmaceutical Sciences, Vol. 15, no. 2, Aug. 2025, pp. 20-39, doi:10.24092/CRPS.2025.150201.
Section
Review Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
.